IUSTI guidelines are intended for use by specialists in the field of sexually transmitted infections. Nothing in these guidelines is intended to supersede or substitute for the normal doctor – patient relationship. The guidelines are produced on behalf of the following organisations: IUSTI Europe; the European Academy of Dermatology and Venereology (EADV); the European Dermatology Forum (EDF); the European Society of Clinical Microbiology and Infectious Diseases (ESCMID); International Society for Infectious Diseases in Obstetrics and Gynaecology (ISIDOG). The European Centre for Disease Prevention and Control (ECDC) and the European Office of the World Health Organisation (WHO-Europe) also contributed to their development.
Current guidelines have been through a substantial editorial and peer review process. The 2020 agreed protocol for the production of European guidelines is available here. The current editorial board is listed here.
Patient information leaflets are produced by expert clinicians and have been through a peer review process available here.
Partner Management (2015) Under review, contact Keith Radcliffe with comments
HIV testing (2014) Under review, contact Raj Patel with comments
Organisation of a consultation for sexually transmitted diseases (2019).
MANAGEMENT OF SPECIFIC INFECTIONS
Genital herpes (2017)
Hepatitis B and C (2017)
Lymphogranuloma venereum (2019)
Molluscum contagiosum (2020)
Mycoplasma genitalium (2016) Under review, please contact Magnus Unemo with comments
Pediculosis Pubis (2017)
Syphilis (2020) | Polish version (2015)
Urogenital Mycoplasmas other than M. genitalium
MANAGEMENT OF SYNDROMES
Balanoposthitis (2014) under review, please contact Willem van der Meijden with comments
Non-gonococcal urethritis (2016) under review please contact Andy Winter with comments
Pelvic inflammatory disease (2017)
Proctitis (2013). under review, contact Jonathan Ross with comments
Sexually acquired reactive arthritis (2014)
Vaginal Discharge (2018).
Vulval conditions (2016)
DRAFT GUIDELINES FOR COMMENTS